Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash from Operations (2018 - 2019)

Historic Cash from Operations for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$1.9 million.

  • DiaMedica Therapeutics' Cash from Operations rose 184.21% to -$1.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$9.1 million, marking a year-over-year decrease of 5979.63%. This contributed to the annual value of -$22.1 million for FY2024, which is 1800.51% down from last year.
  • DiaMedica Therapeutics' Cash from Operations amounted to -$1.9 million in Q4 2019, which was up 184.21% from -$1.2 million recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Cash from Operations registered a high of -$935000.0 during Q1 2018, and its lowest value of -$3.1 million during Q1 2019.